Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection

Bone Marrow Transplantation

Volumn 21, Issue 2, 1998, Pages 123-126

  Vanasek J ^a   Filip, S ^a   Medkova V ^a   Blaha M ^a   Mericka P ^a   Volenec, K ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Autologous transplantation; Breast carcinoma; CD34+ cells; CFU GM; G CSF; Peripheral stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; LEUKOPENIA; PRIORITY JOURNAL; STEM CELL; THROMBOCYTOPENIA;

EID: 2642611977     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701058     Document Type: Article

References (22)

1. Antman K, Armitage JO, Horowitz MM. Autotransplants for breast cancer in North America. Proc Am Soc Clin Oncol 1994; 13: 69-72.
2. Pettengell R, Wohl PJ, Thatcher N et al. Multicyclic dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 1995; 13: 148-156.
3. Jones HM, Jones SA, Watts MJ et al. Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 1994; 12: 1693-1702.
4. Fenelly D, Vahdat L, Schneider J et al. High-intensity chemotherapy with peripheral blood progenitor cell support. Semin Oncol 1994; 21: 21-25.
5. Ossenkoppele GJ, Jonkhoff AR, Huijgens PC et al. Peripheral blood progenitors mobilized by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma. Bone Marrow Transplant 1994; 13: 37-41.
6. Bláha M, Maisnar V, Jebavý L et al. Transplantace kmenov yen buněk krvetvorby z periferni krve. Voj zdrav Listy 1990; 59: 218-223 (Peripheral blood stem cell transplantation, in Czech).
7. Pettengell R, Demuynck H, Testa NG, Dexter TM. The engraftment capacity of peripheral progenitor cells (PBPC) mobilized with chemotherapy ±G-CSF. Int J Cell Clon 1992; 10: 59-61.
8. Demirer T, Bensinger WI. Optimization of peripheral blood stem cell collection. Curr Opin Hematol 1995; 2: 219-226.
9. Sutherland HJ, Eaves CJ, Lansdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
10. Bláha M, Filip S, Měřička P et al. Whole blood instead of peripheral stem cell concentrates - technical considerations. Int J Hematol 1996; 64 (Suppl. 1): 138 (Abstr.).
11. Bláha M, Filip S, Měficka P et al. Peripheral stem cell concentrates for transplantation - our technical and clinical experience. In: Trombóza a hemostáza. Galén: Praha, 1995, pp 91-92.
12. Kröger N, Zschaber R, Krüger W et al. Dose intensity of chemotherapy in breast cancer. Results of clinical studies. Onkologie 1995; 18: 419-428.
13. Richel DJ, Van Der Wall E, Slaper J et al. Peripheral blood stem cell (PBSC) mobilization and transplantation (PSCT) in patients with malignant lymphomas and solid tumors, Int J Artif Organs 1993; 16: 71-75.
14. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-1039.
15. Hénon PR. Comparative cost analysis of autologous blood cell transplantation and autologous bone marrow transplantation. Blood 1994; 84 (Suppl. 1): 87.
16. Uyl-de-Groot CA, Ossenkoppele GJ, van Riet AAPM, Rutten FFH. The cost of peripheral blood progenitor cell reinfusion mobilized by granulocyte colony-stimulating factor following high-dose melphalan as compared with conventional therapy in multiple myeloma. Eur J Cancer 1994; 30A: 457-459.
17. Erban J, Miller K, Berkman E et al. Filgrastim priming of PBSC and hematopoietic reconstitution following high-dose chemotherapy for breast cancer: effect of dose on PBSC yield and engraftment. Proc Am Soc Clin Oncol 1995; 14: (Abstr. 929).
18. + peripheral blood progenitor cells (PBPC) in patients with responding metastatic breast cancer (MBC) undergoing high-dose chemotherapy. Proc Am Soc Clin Oncol 1995; 14: (Abstr. 919).
19. Haas R, Ho AD, Bredthauer U et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factors. Exp Hematol 1990; 18: 94-98.
20. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992;339:640-644.
21. Boogaerts MA. Application of peripheral progenitor cells -results of an ESO task meeting. The European Cancer Conference, Paris, October 29-November 2, 1995.
22. Hutchinson RM, Bell AJ, Duguid JKM et al. Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation. Transfus Med 1994; 4: 165-172.